Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Perioperative Care | 3 | 2018 | 1037 | 0.540 |
Why?
|
| Vasopressins | 1 | 2017 | 355 | 0.520 |
Why?
|
| Intubation, Intratracheal | 4 | 2018 | 1328 | 0.510 |
Why?
|
| Plasma | 1 | 2017 | 584 | 0.450 |
Why?
|
| Vasoconstrictor Agents | 1 | 2017 | 651 | 0.440 |
Why?
|
| Vasodilator Agents | 1 | 2017 | 978 | 0.420 |
Why?
|
| Erythrocyte Transfusion | 1 | 2017 | 566 | 0.410 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 1523 | 0.360 |
Why?
|
| Quality Assurance, Health Care | 1 | 2018 | 2176 | 0.300 |
Why?
|
| Anesthesia | 2 | 2018 | 1584 | 0.300 |
Why?
|
| Intraoperative Complications | 3 | 2007 | 1186 | 0.260 |
Why?
|
| Anesthetics | 2 | 2021 | 522 | 0.230 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2018 | 1259 | 0.210 |
Why?
|
| Awareness | 1 | 2007 | 646 | 0.210 |
Why?
|
| Blood Pressure | 2 | 2017 | 8525 | 0.200 |
Why?
|
| Anesthesia, General | 2 | 2007 | 1166 | 0.190 |
Why?
|
| Southeastern United States | 1 | 2018 | 90 | 0.160 |
Why?
|
| Nevirapine | 1 | 1998 | 273 | 0.150 |
Why?
|
| Hepatic Encephalopathy | 1 | 1998 | 144 | 0.140 |
Why?
|
| Duodenum | 1 | 2019 | 486 | 0.140 |
Why?
|
| Latex | 1 | 1996 | 49 | 0.130 |
Why?
|
| Laminectomy | 1 | 2017 | 224 | 0.130 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 465 | 0.130 |
Why?
|
| Aneurysm, Ruptured | 1 | 2021 | 460 | 0.130 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 1998 | 618 | 0.120 |
Why?
|
| Palpation | 1 | 1995 | 166 | 0.120 |
Why?
|
| Rectum | 1 | 2019 | 895 | 0.120 |
Why?
|
| Monitoring, Intraoperative | 2 | 2017 | 942 | 0.120 |
Why?
|
| Blood Pressure Determination | 1 | 2017 | 640 | 0.110 |
Why?
|
| Child Behavior Disorders | 1 | 1998 | 805 | 0.110 |
Why?
|
| Community Health Services | 1 | 2018 | 654 | 0.110 |
Why?
|
| Suicidal Ideation | 1 | 2022 | 1425 | 0.100 |
Why?
|
| Cardiovascular System | 1 | 2018 | 850 | 0.090 |
Why?
|
| Intracranial Aneurysm | 1 | 2021 | 1276 | 0.090 |
Why?
|
| Suicide | 1 | 2022 | 1599 | 0.090 |
Why?
|
| Mortality | 2 | 2018 | 2916 | 0.090 |
Why?
|
| Parent-Child Relations | 1 | 1994 | 758 | 0.080 |
Why?
|
| Quality Indicators, Health Care | 1 | 2018 | 1822 | 0.080 |
Why?
|
| Spinal Fusion | 1 | 2017 | 1281 | 0.070 |
Why?
|
| Hypersensitivity | 1 | 1996 | 1155 | 0.070 |
Why?
|
| Medication Adherence | 1 | 2018 | 2165 | 0.070 |
Why?
|
| Child Development | 1 | 1998 | 2285 | 0.070 |
Why?
|
| Anti-HIV Agents | 2 | 1998 | 4491 | 0.060 |
Why?
|
| Aortic Valve Stenosis | 1 | 1998 | 2065 | 0.060 |
Why?
|
| Parents | 2 | 2022 | 3549 | 0.060 |
Why?
|
| Incidence | 3 | 2018 | 21391 | 0.060 |
Why?
|
| HIV Infections | 4 | 2019 | 17165 | 0.060 |
Why?
|
| Female | 17 | 2019 | 391246 | 0.060 |
Why?
|
| Retrospective Studies | 5 | 2020 | 80345 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2018 | 8022 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 1998 | 4446 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 14494 | 0.050 |
Why?
|
| Aged | 7 | 2018 | 169143 | 0.050 |
Why?
|
| Male | 16 | 2019 | 359718 | 0.050 |
Why?
|
| Humans | 21 | 2022 | 760613 | 0.050 |
Why?
|
| Mental Recall | 1 | 2007 | 1206 | 0.050 |
Why?
|
| Hospitalization | 1 | 2020 | 10789 | 0.040 |
Why?
|
| Prevalence | 1 | 2017 | 15686 | 0.040 |
Why?
|
| CD4-CD8 Ratio | 1 | 2019 | 114 | 0.040 |
Why?
|
| Middle Aged | 11 | 2018 | 220359 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2020 | 15679 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2018 | 54306 | 0.040 |
Why?
|
| Mid-Atlantic Region | 1 | 2018 | 24 | 0.040 |
Why?
|
| Thiopental | 1 | 1998 | 55 | 0.040 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 1998 | 43 | 0.040 |
Why?
|
| Succinylcholine | 1 | 1998 | 66 | 0.040 |
Why?
|
| Escape Reaction | 1 | 1998 | 57 | 0.040 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 1999 | 246 | 0.040 |
Why?
|
| Infant | 7 | 2022 | 36053 | 0.040 |
Why?
|
| Defense Mechanisms | 1 | 1998 | 180 | 0.040 |
Why?
|
| Aortic Coarctation | 1 | 1999 | 282 | 0.040 |
Why?
|
| Blood | 1 | 2019 | 586 | 0.040 |
Why?
|
| Child, Preschool | 7 | 2022 | 42056 | 0.040 |
Why?
|
| Didanosine | 1 | 1996 | 151 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 58980 | 0.030 |
Why?
|
| Time | 1 | 2018 | 545 | 0.030 |
Why?
|
| Dissociative Disorders | 1 | 1998 | 233 | 0.030 |
Why?
|
| Cardiac Output | 1 | 1998 | 838 | 0.030 |
Why?
|
| Pregnancy | 1 | 2017 | 29746 | 0.030 |
Why?
|
| Bronchoscopes | 1 | 1995 | 64 | 0.030 |
Why?
|
| Anesthetics, Intravenous | 1 | 1998 | 397 | 0.030 |
Why?
|
| Fentanyl | 1 | 1998 | 434 | 0.030 |
Why?
|
| Isoflurane | 1 | 1998 | 384 | 0.030 |
Why?
|
| Ribavirin | 1 | 1996 | 396 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2019 | 1870 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2021 | 64981 | 0.030 |
Why?
|
| Sternum | 1 | 1995 | 175 | 0.030 |
Why?
|
| Educational Status | 1 | 2022 | 2514 | 0.030 |
Why?
|
| Adolescent | 8 | 2022 | 87809 | 0.030 |
Why?
|
| Spinal Dysraphism | 1 | 1996 | 174 | 0.030 |
Why?
|
| Adult | 10 | 2020 | 220007 | 0.030 |
Why?
|
| Risk Factors | 2 | 2017 | 74333 | 0.030 |
Why?
|
| Patient Admission | 1 | 2020 | 1385 | 0.030 |
Why?
|
| Anesthetics, Inhalation | 1 | 1998 | 574 | 0.030 |
Why?
|
| Sex Distribution | 1 | 1998 | 2294 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 1998 | 908 | 0.030 |
Why?
|
| Life Change Events | 1 | 1998 | 952 | 0.030 |
Why?
|
| Surface Properties | 1 | 1995 | 1161 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15760 | 0.030 |
Why?
|
| Child | 8 | 2022 | 79799 | 0.020 |
Why?
|
| Pressure | 1 | 1995 | 1156 | 0.020 |
Why?
|
| Arousal | 1 | 1998 | 1157 | 0.020 |
Why?
|
| Infant, Newborn | 4 | 2022 | 26179 | 0.020 |
Why?
|
| Cerebral Palsy | 1 | 1996 | 471 | 0.020 |
Why?
|
| Bronchi | 1 | 1995 | 848 | 0.020 |
Why?
|
| Acyclovir | 1 | 1992 | 269 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2019 | 1894 | 0.020 |
Why?
|
| Vidarabine | 1 | 1992 | 336 | 0.020 |
Why?
|
| Poverty | 1 | 2022 | 2695 | 0.020 |
Why?
|
| Hypotension | 1 | 1996 | 883 | 0.020 |
Why?
|
| Linear Models | 1 | 2019 | 5877 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 1996 | 814 | 0.020 |
Why?
|
| Herpes Zoster | 1 | 1992 | 251 | 0.020 |
Why?
|
| Mast Cells | 1 | 1996 | 1390 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5496 | 0.020 |
Why?
|
| Anaphylaxis | 1 | 1996 | 755 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 3022 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6771 | 0.020 |
Why?
|
| Equipment Design | 1 | 1995 | 3520 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4353 | 0.020 |
Why?
|
| Hospitals | 1 | 2020 | 3928 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 1998 | 2628 | 0.020 |
Why?
|
| Homeostasis | 1 | 1998 | 3306 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 1992 | 857 | 0.020 |
Why?
|
| Heart Rate | 1 | 1998 | 4180 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 1998 | 2325 | 0.020 |
Why?
|
| Heart | 1 | 2018 | 4393 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 1998 | 3880 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 1996 | 3061 | 0.010 |
Why?
|
| Social Support | 1 | 1994 | 2145 | 0.010 |
Why?
|
| Meningitis, Viral | 1 | 1983 | 50 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1998 | 8055 | 0.010 |
Why?
|
| Emotions | 1 | 1994 | 2734 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1994 | 3985 | 0.010 |
Why?
|
| HIV-1 | 1 | 1996 | 6849 | 0.010 |
Why?
|
| Spinal Cord Ischemia | 1 | 1999 | 93 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 41337 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 1982 | 755 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1995 | 20080 | 0.010 |
Why?
|
| Giant Cells | 1 | 1996 | 185 | 0.010 |
Why?
|
| Viremia | 1 | 1996 | 707 | 0.010 |
Why?
|
| Neuritis | 1 | 1992 | 36 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1996 | 1428 | 0.010 |
Why?
|
| Skin Diseases, Infectious | 1 | 1992 | 77 | 0.010 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1992 | 141 | 0.010 |
Why?
|
| Meningoencephalitis | 1 | 1992 | 83 | 0.010 |
Why?
|
| Brain | 1 | 1998 | 26951 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1982 | 3142 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1996 | 2569 | 0.010 |
Why?
|
| RNA, Viral | 1 | 1996 | 2838 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1992 | 2235 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1996 | 6498 | 0.000 |
Why?
|
| Echovirus 9 | 1 | 1983 | 1 | 0.000 |
Why?
|
| Echovirus Infections | 1 | 1983 | 7 | 0.000 |
Why?
|
| Enterovirus B, Human | 1 | 1983 | 47 | 0.000 |
Why?
|
| Coxsackievirus Infections | 1 | 1983 | 42 | 0.000 |
Why?
|
| Malta | 1 | 1982 | 6 | 0.000 |
Why?
|
| Education, Special | 1 | 1983 | 86 | 0.000 |
Why?
|
| Adenovirus Infections, Human | 1 | 1983 | 73 | 0.000 |
Why?
|
| Enterovirus | 1 | 1983 | 67 | 0.000 |
Why?
|
| Brain Damage, Chronic | 1 | 1983 | 267 | 0.000 |
Why?
|
| Genetic Variation | 1 | 1996 | 6552 | 0.000 |
Why?
|
| Herpes Simplex | 1 | 1983 | 478 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1992 | 5508 | 0.000 |
Why?
|
| Intelligence | 1 | 1983 | 919 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1992 | 12427 | 0.000 |
Why?
|
| Pneumonia, Viral | 1 | 1992 | 3205 | 0.000 |
Why?
|
| Disabled Persons | 1 | 1983 | 1223 | 0.000 |
Why?
|
| Mothers | 1 | 1982 | 2186 | 0.000 |
Why?
|
| Sex Factors | 1 | 1982 | 10546 | 0.000 |
Why?
|
| Age Factors | 1 | 1982 | 18413 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1983 | 39262 | 0.000 |
Why?
|
Concepts
(172)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_